The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Liver fibrosis: Direct antifibrotic agents and targeted therapies
Abstract
Liver fibrosis and in particular cirrhosis are the major causes of morbidity and mortality of patients with chronic liver disease. Their prevention or reversal have become major endpoints in clinical trials with novel liver specific drugs. Remarkable progress has been made with therapies that efficiently address the cause of the underlying liver disease, as in chronic hepatitis B and C. Highly effective antiviral therapy can prevent progression or even induce reversal in the majority of patients, but such treatment remains elusive for the majority of liver patients with advanced alcoholic or nonalcoholic steatohepatitis, genetic or autoimmune liver diseases. Moreover, drugs that would speed up fibrosis reversal are needed for patients with cirrhosis, since even with effective causal therapy reversal is slow or the disease may further progress. Therefore, highly efficient and specific antifibrotic agents are needed that can address advanced fibrosis, i.e., the detrimental downstream result of all chronic liver diseases. This review discusses targeted antifibrotic therapies that address molecules and mechanisms that are central to fibrogenesis or fibrolysis, including strategies that allow targeting of activated hepatic stellate cells and myofibroblasts and other fibrogenic effector cells. Focus is on collagen synthesis, integrins and cells and mechanisms specific including specific downregulation of TGFbeta signaling, major extracellular matrix (ECM) components, ECM-crosslinking, and ECM-receptors such as integrins and discoidin domain receptors, ECM-crosslinking and methods for targeted delivery of small interfering RNA, antisense oligonucleotides and small molecules to increase potency and reduce side effects. With an increased understanding of the biology of the ECM and liver fibrosis and an improved preclinical validation, the translation of these approaches to the clinic is currently ongoing. Application to patients with liver fibrosis and a personalized treatment is tightly linked to the development of noninvasive biomarkers of fibrosis, fibrogenesis and fibrolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Discoidin Domain Receptors: Potential Actors and Targets in Cancer
Rammal, H., Saby, C., Magnien, K., Gulick, L. V., Garnotel, R., Buache, É., Btaouri, H. E., Jeannesson, P., & Morjani, H. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00055 · Cited by 133
RetractedHynes (2002) · doi:10.1016/s0092-8674(02)00971-6 · Cited by 8,606
Schuppan, D., & Afdhal, N. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60383-9 · Cited by 2,089
Self-citationMarcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Fibrosis–a common pathway to organ injury and failure
Rockey, D. C., Bell, P. D., & Hill, J. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1300575 · Cited by 1,428
Macrophage heterogeneity in liver injury and fibrosis
Tacke, F., & Zimmermann, H. W. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.025 · Cited by 1,061
Targeting hepatic macrophages to treat liver diseases
Tacke, F. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.026 · Cited by 1,003
Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Lipid-like materials for low-dose, in vivo gene silencing
Love, K. T., Mahon, K. P., Levins, C. G., Whitehead, K. A., Querbes, W., Dorkin, J. R., Qin, J., Cantley, W., Qin, L. L., Racie, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910603106 · Cited by 969
Raal, F. J., Santos, R. D., Blom, D. J., Marais, A. D., Charng, M.-J., Cromwell, W. C., Lachmann, R. H., Gaudet, D., Tan, J. L., Chasan-Taber, S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60284-x · Cited by 924
Xiao, G., Zhu, S., Xiao, X., Yan, L., Yang, J., & Wu, G. (2017) · Hepatology · doi:10.1002/hep.29302 · Cited by 895
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Henderson, N. C., Arnold, T. D., Katamura, Y., Giacomini, M. M., Rodriguez, J. D., McCarty, J. H., Pellicoro, A., Raschperger, E., Betsholtz, C., Ruminski, P. G., et al. (2013) · Nature Medicine · doi:10.1038/nm.3282 · Cited by 866
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.008 · Cited by 845
Karlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782
A highly durable RNAi therapeutic inhibitor of PCSK9
Fitzgerald, K., White, S., Borodovsky, A., Bettencourt, B. R., Strahs, A., Clausen, V., Wijngaard, P., Horton, J. D., Taubel, J., Brooks, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1609243 · Cited by 768
Hepatic fibrosis: concept to treatment
Trautwein, C., Friedman, S. L., Schuppan, D., & Pinzani, M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.039 · Cited by 677
Self-citationSterile inflammation in the liver
Kubes, P., & Mehal, W. Z. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.09.008 · Cited by 666
Therapy for Fibrotic Diseases: Nearing the Starting Line
Friedman, S. L., Sheppard, D., Duffield, J. S., & Violette, S. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004700 · Cited by 655
Kim, S., Bell, K., Mousa, S. A., & Varner, J. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65005-5 · Cited by 635
Prakash, T. P., Graham, M. J., Yu, J., Carty, R., Low, A., Chappell, A., Schmidt, K., Zhao, C., Aghajan, M., Murray, H. F., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku531 · Cited by 610
Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609
Celiac Disease: From Pathogenesis to Novel Therapies
Schuppan, D., Junker, Y., & Barisani, D. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.09.008 · Cited by 606
Self-citationEvolving therapies for liver fibrosis
Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 595
Self-citationLysyl oxidase: Properties, regulation and multiple functions in biology
Smith-Mungo, L. I., & Kagan, H. M. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90012-9 · Cited by 578
Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis
Georges, P. C., Hui, J.-J., Gombos, Z., McCormick, M. E., Wang, A. Y., Uemura, M., Mick, R., Janmey, P. A., Furth, E. E., & Wells, R. G. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00032.2007 · Cited by 577
Loomba, R., Lawitz, E., Mantry, P. S., Jayakumar, S., Caldwell, S. H., Arnold, H., Diehl, A. M., Djedjos, C. S., Han, L., Myers, R. P., et al. (2018) · Hepatology · doi:10.1002/hep.29514 · Cited by 549
Matrix as a Modulator of Hepatic Fibrogenesis
Schuppan, D., Ruehl, M., Somasundaram, R., & Hahn, E. G. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17556 · Cited by 542
Self-citationIntegrins and the activation of latent transforming growth factor β1 – An intimate relationship
Wipff, P.-J., & Hinz, B. (2008) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.01.012 · Cited by 517
Papatheodoridis, G. V., Chan, H. L.-Y., Hansen, B. E., Janssen, H. L. A., & Lampertico, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.002 · Cited by 511
The good and the bad collagens of fibrosis – Their role in signaling and organ function
Karsdal, M. A., Nielsen, S. H., Leeming, D. J., Langholm, L. L., Nielsen, M. J., Manon-Jensen, T., Siebuhr, A., Gudmann, N. S., Rønnow, S., Sand, J. M., et al. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.014 · Cited by 509
Self-citationHamson, E. J., Keane, F. M., Tholen, S., Schilling, O., & Gorrell, M. D. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300095 · Cited by 496
Richardson, M. M., Jonsson, J. R., Powell, E. E., Brunt, E. M., Neuschwander–Tetri, B. A., Bhathal, P. S., Dixon, J. B., Weltman, M. D., Tilg, H., Moschen, A. R., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.012 · Cited by 482
Determinants of Fibrosis Progression and Regression in NASH
Schuppan, D., Surabattula, R., & Wang, X. Y. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.11.012 · Cited by 479
Self-citationIssa, R., Zhou, X., Constandinou, C. M., Fallowfield, J., Millward-Sadler, H., Gaca, M. D. A., Sands, E., Suliman, I., Trim, N., & Knorr, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.009 · Cited by 456
Oval Cell Numbers in Human Chronic Liver Diseases Are Directly Related to Disease Severity
Lowes, K. N., Brennan, B. A., Yeoh, G. C., & Olynyk, J. K. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65299-6 · Cited by 453
Use of Liver Imaging and Biopsy in Clinical Practice
Tapper, E. B., & Lok, A. S.-F. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1610570 · Cited by 442
Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
Horan, G. S., Wood, S., Ona, V., Li, D. J., Lukashev, M. E., Weinreb, P. H., Simon, K. J., Hahm, K., Allaire, N. E., Rinaldi, N. J., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200706-805oc · Cited by 420
D'Ambrosio, R., Aghemo, A., Rumi, M. G., Ronchi, G., Donato, M. F., Paradis, V., Colombo, M., & Bedossa, P. (2012) · Hepatology · doi:10.1002/hep.25606 · Cited by 409
Kim, K. K., Wei, Y., Szekeres, C., Kugler, M. C., Wolters, P. J., Hill, M. L., Frank, J. A., Brumwell, A. N., Wheeler, S. E., Kreidberg, J. A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36940 · Cited by 397
Structure of the Extracellular Matrix in Normal and Fibrotic Liver: Collagens and Glycoproteins
Schuppan, D. (1990) · Seminars in Liver Disease · doi:10.1055/s-2008-1040452 · Cited by 366
Self-citationHepatic stellate cells require a stiff environment for myofibroblastic differentiation
Olsen, A. L., Bloomer, S. A., Chan, E. P., Gaça, M. D. A., Georges, P. C., Sackey, B., Uemura, M., Janmey, P. A., & Wells, R. G. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00412.2010 · Cited by 355
Omenetti, A., Porrello, A., Jung, Y., Yang, L., Popov, Y., Choi, S. S., Witek, R. P., Alpini, G., Venter, J., Vandongen, H. M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35875 · Cited by 341
Self-citationLevy, M. T., McCaughan, G. W., Abbott, C. A., Park, J. E., Cunningham, A. M., Müller, E., Rettig, W. J., & Gorrell, M. D. (1999) · Hepatology · doi:10.1002/hep.510290631 · Cited by 336
Suhr, O. B., Coelho, T., Buades, J., Pouget, J., Conceicao, I., Berk, J., Schmidt, H., Waddington-Cruz, M., Campistol, J. M., Bettencourt, B. R., et al. (2015) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-015-0326-6 · Cited by 321
The α v β 1 integrin plays a critical in vivo role in tissue fibrosis
Reed, N. I., Jo, H., Chen, C., Tsujino, K., Arnold, T. D., DeGrado, W. F., & Sheppard, D. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5094 · Cited by 311
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies†
Popov, Y., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23123 · Cited by 296
Self-citationIkenaga, N., Peng, Z.-W., Vaid, K. A., Liu, S. B., Yoshida, S., Sverdlov, D. Y., Mikels-Vigdal, A., Smith, V., Schuppan, D., & Popov, Y. V. (2017) · Gut · doi:10.1136/gutjnl-2016-312473 · Cited by 295
Self-citationPharmacotherapy for NASH: Current and emerging
Konerman, M. A., Jones, J. C., & Harrison, S. A. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.10.015 · Cited by 292
DDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells
Olaso, E., Ikeda, K., Eng, F. J., Xu, L.-M., Wang, L., Lin, H. C., & Friedman, S. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12373 · Cited by 291
Pinzani, M., Milani, S., Herbst, H., DeFranco, R., Grappone, C., Gentilini, A., Caligiuri, A., Pellegrini, G., Ngo, D. V., Romanelli, R. G., et al. (1996) · Europe PMC (PubMed Central) · Cited by 286
Raghu, G., Brown, K. K., Collard, H. R., Cottin, V., Gibson, K. F., Kaner, R. J., Lederer, D. J., Martinez, F. J., Noble, P. W., Song, J. W., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30421-0 · Cited by 278
Baeck, C., Wei, X., Bartneck, M., Fech, V., Heymann, F., Gassler, N., Hittatiya, K., Eulberg, D., Luedde, T., Trautwein, C., et al. (2014) · Hepatology · doi:10.1002/hep.26783 · Cited by 270
Popov, Y., Patsenker, E., Fickert, P., Trauner, M., & Schuppan, D. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.06.025 · Cited by 268
Self-citationMilani, S., Herbst, H., Schuppan, D., Stein, H., & Surrenti, C. (1991) · PubMed · Cited by 267
Self-citationNovel insights into the function and dynamics of extracellular matrix in liver fibrosis
Karsdal, M. A., Manon-Jensen, T., Genovese, F., Kristensen, J. H., Nielsen, M. J., Sand, J. M. B., Hansen, N.-U. B., Bay-Jensen, A.-C., Bager, C. L., Krag, A., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00447.2014 · Cited by 263
Self-citationAtabai, K., Jame, S., Azhar, N., Kuo, A., Lam, M., McKleroy, W., DeHart, G., Rahman, S., Xia, D. D., Melton, A. C., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci40053 · Cited by 237
Liu, S. B., Ikenaga, N., Peng, Z., Sverdlov, D. Y., Greenstein, A., Smith, V., Schuppan, D., & Popov, Y. (2016) · The FASEB Journal · doi:10.1096/fj.14-268425 · Cited by 224
Self-citationMartin, K., Pritchett, J., Llewellyn, J., Mullan, A. F., Athwal, V. S., Dobie, R., Harvey, E., Zeef, L., Farrow, S., Streuli, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms12502 · Cited by 219
Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate
Zimmermann, T. S., Karsten, V., Chan, A., Chiesa, J., Boyce, M., Bettencourt, B. R., Hutabarat, R., Nochur, S., Vaishnaw, A., & Gollob, J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.019 · Cited by 216
Ma, L.-J., Yang, H., Gaspert, A., Carlesso, G., Barty, M. M., Davidson, J. M., Sheppard, D., & Fogo, A. B. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63486-4 · Cited by 215
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
Nanthakumar, C. B., Hatley, R. J. D., Lemma, S., Gauldie, J., Marshall, R. P., & Macdonald, S. J. F. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4592 · Cited by 208
Huang, D., Chang, T. R., Aggarwal, A., Lee, R. C., & Ehrlich, H. P. (1993) · Annals of Biomedical Engineering · doi:10.1007/bf02368184 · Cited by 206
Discoidin domain receptors in disease
Borza, C. M., & Pozzi, A. (2014) · Matrix Biology · doi:10.1016/j.matbio.2013.12.002 · Cited by 205
Patsenker, E., Popov, Y., Stickel, F., Jonczyk, A., Goodman, S. L., & Schuppan, D. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.009 · Cited by 200
Self-citationIntegrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma
Gerber, E. E., Gallo, E. M., Fontana, S. C., Davis, E. C., Wigley, F. M., Huso, D. L., & Dietz, H. C. (2013) · Nature · doi:10.1038/nature12614 · Cited by 190
αvβ6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse
Hahm, K., Lukashev, M. E., Luo, Y., Yang, W. J., Dolinski, B. M., Weinreb, P. H., Simon, K. J., Chun Wang, L., Leone, D. R., Lobb, R. R., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060158 · Cited by 190
Kitamura, H., Cambier, S., Somanath, S., Barker, T., Minagawa, S., Markovics, J., Goodsell, A., Publicover, J., Reichardt, L., Jablons, D., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45589 · Cited by 189
Popov, Y., Patsenker, E., Stickel, F., Zaks, J., Bhaskar, K. R., Niedobitek, G., Kolb, A., Friess, H., & Schuppan, D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.021 · Cited by 185
Self-citationPerepelyuk, M., Terajima, M., Wang, A. Y., Georges, P. C., Janmey, P. A., Yamauchi, M., & Wells, R. G. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00222.2012 · Cited by 184
Patsenker, E., Popov, Y., Stickel, F., Schneider, V., Ledermann, M., Sägesser, H., Niedobitek, G., Goodman, S. L., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23144 · Cited by 174
Self-citationThe Role of α1β1 Integrin in Wound Contraction
Racine-Samson, L., Rockey, D. C., & Bissell, D. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30911 · Cited by 174
Nishimura, S. L. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090393 · Cited by 174
Grenard, P., Bresson-Hadni, S., El Alaoui, S., Chevallier, M., Vuitton, D. A., & Ricard-Blum, S. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00135-0 · Cited by 172
Elbjeirami, W. M., Yonter, E. O., Starcher, B. C., & West, J. L. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10021 · Cited by 166
Chen, H., Qu, J., Huang, X., Kurundkar, A., Zhu, L., Yang, N., Venado, A. E., Ding, Q., Liu, G., Antony, V. B., et al. (2016) · Nature Communications · doi:10.1038/ncomms12564 · Cited by 166
Role of αvβ6 integrin in acute biliary fibrosis
Wang, B., Dolinski, B. M., Kikuchi, N., Leone, D. R., Peters, M. G., Weinreb, P. H., Violette, S. M., & Bissell, M. D. (2007) · Hepatology · doi:10.1002/hep.21849 · Cited by 163
αv integrins: key regulators of tissue fibrosis
Conroy, K. P., Kitto, L. J., & Henderson, N. C. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2407-9 · Cited by 160
Tatsukawa, H., Furutani, Y., Hitomi, K., & Kojima, S. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.150 · Cited by 160
The type of collagen cross-link determines the reversibility of experimental skin fibrosis.
van der Slot-Verhoeven, A. J., van Dura, E. A., Attema, J., Blauw, B., DeGroot, J., Huizinga, T., Zuurmond, A., & Bank, R. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2005.02.007 · Cited by 155
Discoidin Domain Receptor 1–deficient Mice are Resistant to Bleomycin-induced Lung Fibrosis
Avivi-Green, C., Singal, M., & Vogel, W. F. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-333oc · Cited by 155
Shweke, N., Boulos, N., Jouanneau, C., Vandermeersch, S., Melino, G., Dussaule, J., Chatziantoniou, C., Ronco, P. M., & Boffa, J. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080025 · Cited by 155
Levy, M. T., McCaughan, G. W., Marinos, G., & Gorrell, M. D. (2002) · Liver International · doi:10.1034/j.1600-0676.2002.01503.x · Cited by 154
Ackermann, E. J., Guo, S., Benson, M. D., Booten, S. L., Freier, S., Hughes, S. G., Kim, T., Kwoh, T. J., Matson, J. E., Norris, D., et al. (2016) · Amyloid · doi:10.1080/13506129.2016.1191458 · Cited by 153
Thomassin, L., WERNECK, C. C., Broekelmann, T. J., Gleyzal, C., Hornstra, I. K., Mecham, R. P., & Sommer, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506832200 · Cited by 150
Couvelard, A., Scoazec, J., & Feldmann, G. (1993) · PubMed · Cited by 148
Beljaars, L., Molema, G., Schuppan, D., Geerts, A. E., Bleser, P. J. D., Weert, B., Meijer, D. K. F., & Poelstra, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.12743 · Cited by 146
Self-citationCalvente, C. J., Sehgal, A., Popov, Y. V., Kim, Y. O., Zevallos, V. F., Şahin, U., Diken, M., & Schuppan, D. (2015) · Hepatology · doi:10.1002/hep.27936 · Cited by 138
Self-citationReal-Time Localization of Parathyroid Adenoma during Parathyroidectomy
Jayender, J., Lee, T. C., & Ruan, D. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1415448 · Cited by 138
Popov, Y. V., Sverdlov, D., Sharma, A. K., Bhaskar, K. R., Li, S., Freitag, T. L., Lee, J. D., Dieterich, W., Melino, G., & Schuppan, D. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.040 · Cited by 137
Self-citationPopov, Y., Sverdlov, D. Y., Bhaskar, K. R., Sharma, A. K., Millonig, G., Patsenker, E., Krahenbuhl, S., Krahenbuhl, L., & Schuppan, D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00394.2009 · Cited by 136
Self-citationDiscoidin Domain Receptor 1 Null Mice Are Protected against Hypertension-Induced Renal Disease
Flamant, M., Placier, S., Rodenas, A., Curat, C. A., Vogel, W. F., Chatziantoniou, C., & Dussaule, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060677 · Cited by 135
Moreno, M., Gonzalo, T., Kok, R. J., Sancho‐Bru, P., van Beuge, M. M., Swart, J., Prakash, J., Temming, K., Fondevila, C., Beljaars, L., et al. (2009) · Hepatology · doi:10.1002/hep.23419 · Cited by 134
Fan, M.-H., Zhu, Q., Li, H., Ra, H.-J., Majumdar, S., Gulick, D. L., Jerome, J. A., Madsen, D. H., Christofidou‐Solomidou, M., Speicher, D. W., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.701433 · Cited by 134
Yasuda, M., Gan, L., Chen, B., Kadirvel, S., Yu, C., Phillips, J. D., New, M. I., Liebow, A., Fitzgerald, K. J., Querbes, W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406228111 · Cited by 133
Atsawasuwan, P., Mochida, Y., Katafuchi, M., Kaku, M., Fong, K. S. K., Csiszár, K., & Yamauchi, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803142200 · Cited by 131
Yang, C., Zeisberg, M., Lively, J. C., Nyberg, P., Afdhal, N. H., & Kalluri, R. (2003) · PubMed · Cited by 130
Weng, S.-Y., Wang, X., Vijayan, S., Tang, Y., Kim, Y. O., Padberg, K., Regen, T., Molokanova, O., Chen, T., Bopp, T., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.01.028 · Cited by 128
Self-citationLysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter
Giampuzzi, M., Botti, G., Duca, M. D., Arata, L., Ghiggeri, G. M., Gusmano, R., Ravazzolo, R., & Donato, A. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003362200 · Cited by 119
Peng, Z., Ikenaga, N., Liu, S. B., Sverdlov, D. Y., Vaid, K. A., Dixit, R., Weinreb, P. H., Violette, S., Sheppard, D., Schuppan, D., et al. (2016) · Hepatology · doi:10.1002/hep.28274 · Cited by 118
Self-citationExpression of the Integrin α8β1 during Pulmonary and Hepatic Fibrosis
Levine, D., Rockey, D. C., Milner, T. A., Breuss, J. M., Fallon, J. T., & Schnapp, L. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65066-3 · Cited by 115
Carloni, V, Romanelli, R., Pinzani, M., Laffi, G., & Gentilini, P. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8613002 · Cited by 113
Discoidin Domain Receptor 1 Mediates Myosin-Dependent Collagen Contraction
Coelho, N. M., Arora, P. D., van Putten, S., Boo, S., Petrovic, P., Lin, A. X., Hinz, B., & McCulloch, C. A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.01.061 · Cited by 110
Role of integrins in fibrosing liver diseases
Patsenker, E., & Stickel, F. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00050.2011 · Cited by 104
Rosenblatt, S., Bassuk, J. A., Alpers, C. E., Sage, H., Timpl, R., & Preissner, K. T. (1997) · Biochemical Journal · doi:10.1042/bj3240311 · Cited by 100
Anti-fibrotic therapy: Lost in translation?
Schuppan, D., & Pinzani, M. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60008-7 · Cited by 97
Self-citationNovel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice
Bansal, R., Prakash, J., Post, E., Beljaars, L., Schuppan, D., & Poelstra, K. (2011) · Hepatology · doi:10.1002/hep.24395 · Cited by 96
Self-citationKlein, S., van Beuge, M. M., Granzow, M., Beljaars, L., Schierwagen, R., Kilic, S., Heidari, I., Huss, S., Sauerbruch, T., Poelstra, K., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.033 · Cited by 93
Phase II Trial of Talabostat and Docetaxel in Advanced Non-small Cell Lung Cancer
Eager, R., Cunningham, C. C., Senzer, N. N., Richards, D., Raju, R. N., Jones, B. N., Uprichard, M. J., & Nemunaitis, J. J. (2009) · Clinical Oncology · doi:10.1016/j.clon.2009.04.007 · Cited by 92
Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery
Kothiwale, S., Borza, C. M., Lowe, E. W., Pozzi, A., & Meiler, J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.025 · Cited by 91
O’Brien, V., Frisch, S. M., & Juliano, R. L. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0130 · Cited by 91
Egger, C., Cannet, C., Gérard, C., Suply, T., Ksiazek, I., Jarman, E., & Beckmann, N. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.05.022 · Cited by 91
Selective Targeting of TGF-β Activation to Treat Fibroinflammatory Airway Disease
Minagawa, S., Lou, J., Seed, R. I., Cormier, A., Wu, S., Cheng, Y., Murray, L., Tsui, P., Connor, J., Herbst, R., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008074 · Cited by 90
Lucero, H. A., Ravid, K., Grimsby, J. L., Rich, C. B., DiCamillo, S. J., Mäki, J. M., Myllyharju, J., & Kagan, H. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709897200 · Cited by 89
Antifibrotic Therapies: Where Are We Now?
Yoon, Y., Lee, Y., & Friedman, S. L. (2016) · Seminars in Liver Disease · doi:10.1055/s-0036-1571295 · Cited by 86
Discoidin domain receptor 2 deficiency predisposes hepatic tissue to colon carcinoma metastasis
Badiola, I., Olaso, E., Crende, O., Friedman, S. L., & Vidal‐Vanaclocha, F. (2011) · Gut · doi:10.1136/gutjnl-2011-300810 · Cited by 85
Zhao, H., Bian, H., Bu, X., Zhang, S., Zhang, P., Yu, J., Lai, X., Li, D., Zhu, C., Yao, L., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.109 · Cited by 84
Antifibrotic Therapies in the Liver
Schuppan, D., & Mehal, W. Z. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550055 · Cited by 81
Self-citationMazur, A., Holthoff, E. R., Vadali, S., Kelly, T. J., & Post, S. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150287 · Cited by 78
Biochemical and immunochemical study of lysyl oxidase in experimental hepatic fibrosis in the rat.
Siegel, R. C., Chen, K. H., Greenspan, J. S., & Aguiar, J. M. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2945 · Cited by 77
Yu, R. Z., Gunawan, R., Post, N. M., Zanardi, T. A., Hall, S., Burkey, J., Kim, T., Graham, M. J., Prakash, T. P., Seth, P. P., et al. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2016.0623 · Cited by 75
Torok, N. J., Dranoff, J. A., Schuppan, D., & Friedman, S. L. (2015) · Hepatology · doi:10.1002/hep.27720 · Cited by 74
Self-citationTruffi, M., Sorrentino, L., Monieri, M., Fociani, P., Mazzucchelli, S., Bonzini, M., Zerbi, P., Sampietro, G. M., Sabatino, A. D., & Corsi, F. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx008 · Cited by 74
Pharmacologic Blockade of αvβ1 Integrin Ameliorates Renal Failure and Fibrosis In Vivo
Chang, Y., Lau, W. L., Jo, H., Tsujino, K., Gewin, L. S., Reed, N. I., Atakilit, A., Nunes, A. C. F., DeGrado, W. F., & Sheppard, D. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050585 · Cited by 72
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles
Leber, N., Kaps, L., Aslam, M., Schupp, J., Brose, A., Schaeffel, D., Fischer, K., Diken, M., Strand, D. J., Koynov, K., et al. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.12.006 · Cited by 71
Self-citationJuillerat‐Jeanneret, L., Tafelmeyer, P., & Golshayan, D. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1370455 · Cited by 71
Impact of hepatitis C virus eradication on hepatocellular carcinogenesis
Li, D. K., & Chung, R. T. (2015) · Cancer · doi:10.1002/cncr.29528 · Cited by 69
Wang, Z., Bian, H., Bartual, S. G., Du, W., Luo, J., Zhao, H., Zhang, S., Mo, C., Zhou, Y., Xu, Y., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00140 · Cited by 67
Olaso, E., Arteta, B., Benedicto, A., Crende, O., & Friedman, S. L. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.002 · Cited by 66
Targeted therapy of liver fibrosis/cirrhosis and its complications
Poelstra, K., & Schuppan, D. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.04.008 · Cited by 62
Self-citationHeterogeneity of liver cells expressing procollagen types I and IV in vivo
Herbst, H., Frey, A., Heinrichs, O., Milani, S., Bechstein, W. O., Neuhaus, P., & Schuppan, D. (1997) · Histochemistry and Cell Biology · doi:10.1007/s004180050126 · Cited by 60
Self-citationLiver Bid suppression for treatment of fibrosis associated with non-alcoholic steatohepatitis
Eguchi, A., du Jeu, X. D. M., Johnson, C. D., Andronikou, N., & Feldstein, A. E. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.11.002 · Cited by 60
Mechanical signaling through the discoidin domain receptor 1 plays a central role in tissue fibrosis
Coelho, N. M., & McCulloch, C. A. (2018) · Cell Adhesion & Migration · doi:10.1080/19336918.2018.1448353 · Cited by 60
In Vivo Gene‐Silencing in Fibrotic Liver by siRNA‐Loaded Cationic Nanohydrogel Particles
Kaps, L., Nuhn, L., Aslam, M., Brose, A., Foerster, F., Rosigkeit, S., Renz, P., Heck, R., Kim, Y. O., Lieberwirth, I., et al. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500826 · Cited by 55
Self-citationNejjari, M., Couvelard, A., Mosnier, J., Moreau, A., Feldmann, G., Degott, C., Marcellin, P., & Scoazec, J. (2001) · The Journal of Pathology · doi:10.1002/path.964 · Cited by 51
Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis
Borza, C. M., Su, Y. R., Tran, T., Yu, L., Steyns, N., Temple, K. J., Skwark, M. J., Meiler, J., Lindsley, C. W., Hicks, B. R., et al. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.11.009 · Cited by 49
The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease
Dorison, A., Dussaule, J., & Chatziantoniou, C. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000479119 · Cited by 49
Sugiyama, A., Kanno, K., Nishimichi, N., Ohta, S., Ono, J., Conway, S. J., Izuhara, K., Yokosaki, Y., & Tazuma, S. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1206-0 · Cited by 48
Howe, G. A., Xiao, B., Zhao, H., Al‐Zahrani, K. N., Hasim, M. S., Villeneuve, J., Sekhon, H. S., Goss, G. D., Sabourin, L. A., Dimitroulakos, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150567 · Cited by 47
Civitarese, R., Talior‐Volodarsky, I., Desjardins, J., Kabir, G., Switzer, J., Mitchell, M., Kapùs, A., McCulloch, C. A., Gullberg, D., & Connelly, K. A. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00918.2015 · Cited by 47
Bryant, J. E., Shamhart, P. E., Luther, D. J., Olson, E. R., Koshy, J. C., Costic, D. J., Mohile, M. V., Dockry, M., Doane, K. J., & Meszaros, J. G. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.10.022 · Cited by 45
Coordinated expression of integrin α6β1 and laminin in hepatocellular carcinoma
Torimura, T., Ueno, T., Kin, M., Inuzuka, S., Sugawara, H., Tamaki, S., Tsuji, R., Sujaku, K., Sata, M., & Tanikawa, K. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90250-1 · Cited by 41
Song, S., Shackel, N. A., Wang, X. M., Ajami, K., McCaughan, G. W., & Gorrell, M. D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.11.068 · Cited by 40
FIUME, L., & Favilli, G. (1961) · Nature · doi:10.1038/189071a0 · Cited by 39
Waldmann, E., Vogt, A., Crispin, A., Altenhofer, J., Riks, I., & Parhofer, K. G. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.02.019 · Cited by 39
van Beuge, M. M., Prakash, J., Lacombe, M., Post, E., Reker‐Smit, C., Beljaars, L., & Poelstra, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056442 · Cited by 35
Molokanova, O., Schönig, K., Weng, S., Wang, X., Bros, M., Diken, M., Ohngemach, S., Karsdal, M. A., Strand, D. J., Nikolaev, A., et al. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.11.002 · Cited by 35
Self-citationKerroch, M., Alfieri, C., Dorison, A., Boffa, J., Chatziantoniou, C., & Dussaule, J. (2016) · Scientific Reports · doi:10.1038/srep21262 · Cited by 32
Huang, G., & Brigstock, D. R. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01072.x · Cited by 31
Marek, I., Lichtneger, T., Cordasic, N., Hilgers, K. F., Volkert, G., Fahlbusch, F. B., Rascher, W., Hartner, A., & Menendez‐Castro, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150471 · Cited by 31
Lu, Y., Zhao, X., Yu, L., Qi, F., Zhai, B., Gao, C., & Ding, Q. (2017) · Scientific Reports · doi:10.1038/srep46357 · Cited by 31
van Dijk, F., Teekamp, N., Beljaars, L., Post, E., Zuidema, J., Steendam, R., Kim, Y. O., Frijlink, H. W., Schuppan, D., Poelstra, K., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.029 · Cited by 27
Self-citationHerck, J. L., Schrijvers, D. M., Meyer, G. R. Y. D., Martinet, W., Hove, C. E. V., Bult, H., Vrints, C. J., & Herman, A. G. (2009) · Journal of Vascular Research · doi:10.1159/000255966 · Cited by 26
Guo, S., Booten, S. L., Watt, A. T., Alvarado, L., Freier, S. M., Teckman, J. H., McCaleb, M. L., & Monia, B. P. (2014) · Rare Diseases · doi:10.4161/rdis.28511 · Cited by 19
Jiang, Y., Xin, X., & Lu, S. (2009) · PubMed · Cited by 7
Cited by
Molecular and cellular mechanisms of liver fibrosis and its regression
Kisseleva, T., & Brenner, D. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00372-7 · Cited by 2,024
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2020.10.001 · Cited by 851
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019) · Cells · doi:10.3390/cells8111419 · Cited by 837
Metadata
- Authors
- Schuppan, D., Ashfaq-Khan, M., Yang, A. T., & Kim, Y. O.
- Venue
- Matrix Biology
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 68-69
- Pages
- 435-451
- ISSN
- 0945-053X (ISSN-L)
- OpenAlex
- W2796699845
- Cited by
- 435
- References
- 156
- FWCI
- 24.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.